Cargando…

Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation

We report a case of partial diazoxide responsiveness in a child with severe congenital hyperinsulinaemic hypoglycaemia (CHI) due to a homozygous ABCC8 mutation. A term baby, with birth weight 3.8 kg, born to consanguineous parents presented on day 1 of life with hypoglycaemia. Hypoglycaemia screen c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiff, Sarah, Babb, Carolyn, Guemes, Maria, Dastamani, Antonia, Gilbert, Clare, Flanagan, Sarah E, Ellard, Sian, Barton, John, Dattani, M, Shah, Pratik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Unusual Effects of Medical Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373619/ https://www.ncbi.nlm.nih.gov/pubmed/30753133 http://dx.doi.org/10.1530/EDM-18-0120

Ejemplares similares

Diazoxide-unresponsive congenital hyperinsulinism associated with ABCC8 nonsense mutation
por: Hussain, Suhaimi, et al.
Publicado: (2015)

Exceptional diazoxide sensitivity in hyperinsulinaemic hypoglycaemia due to a novel HNF4A mutation
por: Arya, Ved Bhushan, et al.
Publicado: (2019)

Central venous catheter-associated thrombosis in children with congenital hyperinsulinism
por: Yau, Daphne, et al.
Publicado: (2019)

Congenital Hyperinsulinism and Evolution to Sulfonylurearesponsive Diabetes Later in Life due to a Novel Homozygous p.L171F ABCC8 Mutation
por: Işık, Emregül, et al.
Publicado: (2019)

Sirolimus: Efficacy and Complications in Children With Hyperinsulinemic Hypoglycemia: A 5-Year Follow-Up Study
por: Maria, Güemes, et al.
Publicado: (2019)

Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11
por: Hewat, Thomas I., et al.
Publicado: (2021)

A novel mutation of ABCC8 gene in a patient with diazoxide-unresponsive congenital hyperinsulinism
por: Park, Ji Sook, et al.
Publicado: (2016)

Sirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia
por: Loke, Kah-Yin, et al.
Publicado: (2016)

Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy
por: Arya, Ved Bhushan, et al.
Publicado: (2014)

Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism
por: Chandran, Suresh, et al.
Publicado: (2013)

Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation
por: Mooij, Christiaan F., et al.
Publicado: (2021)

Novel Compound Heterozygous Variants of the ABCC8 Gene Warrant Identification of Pancreatic Histology in Infant with Diazoxide-unresponsive Congenital Hyperinsulinism
por: Al Balwi, Rana, et al.
Publicado: (2021)

Spectrum of neuro-developmental disorders in children with congenital hyperinsulinism due to activating mutations in GLUD1
por: Aftab, Sommayya, et al.
Publicado: (2022)

Diazoxide-Induced Hypertrichosis in a Neonate With Transient Hyperinsulinism
por: Boskabadi, Seyyed Javad, et al.
Publicado: (2023)

Diazoxide-responsive hyperinsulinaemic hypoglycaemia in tyrosinaemia type 1
por: Sotiridou, Ellada, et al.
Publicado: (2021)

Successful medical management of insulinoma with diazoxide for 27 years
por: Warren, Annabelle M, et al.
Publicado: (2020)

Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389
por: Yau, Daphne, et al.
Publicado: (2020)

A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus
por: Ünal, Sevim, et al.
Publicado: (2016)

Reversible alterations in cardiac morphology and functions in a patient with Cushing's syndrome
por: Iwasaki, Hiroaki
Publicado: (2014)

Painful fat necrosis resulting from insulin injections
por: Hanson, P, et al.
Publicado: (2014)

Intermittent everolimus administration for malignant insulinoma
por: Baratelli, Chiara, et al.
Publicado: (2014)

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin
por: Lima-Martínez, Marcos M, et al.
Publicado: (2014)

Methimazole-induced myositis: a case report and review of the literature
por: Bou Khalil, R, et al.
Publicado: (2013)

Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone
por: Dow, Adrienne, et al.
Publicado: (2013)

GH replacement causing acute hyperglycaemia and ketonuria in a type 1 diabetic patient
por: Cavlan, Dominic, et al.
Publicado: (2013)

Adrenal insufficiency in acute oral opiate therapy
por: Policola, Caterina, et al.
Publicado: (2014)

Adrenal insufficiency in a woman secondary to standard-dose inhaled fluticasone propionate therapy
por: Hay, Casey M, et al.
Publicado: (2014)

Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
por: Kaur, Arshpreet, et al.
Publicado: (2015)

Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia
por: Lee, Angela S, et al.
Publicado: (2015)

Onset of Graves' disease during long-term immunosuppressive therapy in a patient with membranous nephropathy
por: Iwasaki, Hiroaki
Publicado: (2015)

A case of thyroid storm complicated by acute hepatitis due to propylthiouracil treatment
por: Tufton, Nicola, et al.
Publicado: (2015)

Estradiol: micrograms or milligrams
por: Kirk, Jeremy M W, et al.
Publicado: (2016)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

Prolonged life-threatening hypoglycaemia following dose escalation of octreotide LAR in a patient with malignant polysecreting pancreatic neuroendocrine tumour
por: Abell, Sally K, et al.
Publicado: (2015)

A novel melanoma therapy stirs up a storm: ipilimumab-induced thyrotoxicosis
por: Yu, Christine, et al.
Publicado: (2015)

A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology
por: Sbardella, Emilia, et al.
Publicado: (2016)

Hyponatraemia secondary to nivolumab-induced primary adrenal failure
por: Trainer, Harris, et al.
Publicado: (2016)

Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
por: Alvarez-Escola, Cristina, et al.
Publicado: (2016)

Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2016)

Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing’s syndrome in a medullary thyroid carcinoma patient
por: Bseiso, Hashem, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rraalmifm80su2iir4u2bq7068